Future-proofing drug development with GenAI
Drug Target Review
JULY 3, 2025
With up to 90 percent of assets never making it to market when competition is at an all-time high, it is worth discussing how AI-driven approaches might help set a stronger foundation for possibilities downstream. Grounding LLMs with particular datasets and engineering prompts helps you access the appropriate data. Acta Pharm Sin B.
Let's personalize your content